Please login to the form below

Not currently logged in
Email:
Password:

C4X Discovery appoints chief executive officer

Executive chairman Clive Dix takes on the lead role

C4X Discovery Clive DixManchester, UK-based drug discovery and development company C4X Discovery has appointed Clive Dix as its new chief executive officer.

Dix will take on his new role immediately, relinquishing his previous role as the firm's executive chairman.

He joined C4X Discovery in 2014 as non-executive chairman, bringing over 30 years of experience in the pharmaceutical and biotechnology industries to the firm.

Since joining GlaxoSmithKline's research department in 1988, Dix has held a series of senior leadership positions including chief executive officer of Convergence Pharmaceuticals and chairman of both Crescendo Biologics and Modern Biosciences.

In addition to his new role at C4X Discovery, Dix also serves as chairman of Calchan Limited, Centauri Therapeutics and Touchlight Genetics.

Dix said: “Having seen from an executive position the potential of the platform to generate entirely new compounds against high-value therapeutic targets more rapidly and efficiently than any technology I've come across before and having witnessed the interest we're receiving in C4X Discovery, I am delighted to take the helm on a full-time basis.

“I have never been more excited by a company than this one.”

6th May 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics